Similarly, a study by Coustan-Smith et al. [19] identified 22 differentially expressed markers, including CD44, CD73, and CD123, which are upregulated in BCP-ALL compared to normal B cells. This evidence concerns the gene NT5E and acute lymphoblastic leukemia.